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Abstract
Background: Pulmonary rehabilitation (PR) is an effective intervention for the management of people with chronic
obstructive pulmonary disease (COPD). However, available resources are often limited, and many patients bear with
poor availability of programmes. Sustaining PR benefits and regular exercise over the long term is difficult without
any exercise maintenance strategy. In contrast to traditional centre-based PR programmes, telerehabilitation may
promote more effective integration of exercise routines into daily life over the longer term and broaden its applicability
and availability. A few studies showed promising results for telerehabilitation, but mostly with short-term interventions.
The aim of this study is to compare long-term telerehabilitation with unsupervised exercise training at home and with
standard care.
Methods/Design: An international multicentre randomised controlled trial conducted across sites in three countries
will recruit 120 patients with COPD. Participants will be randomly assigned to telerehabilitation, treadmill and control,
and followed up for 2 years. The telerehabilitation intervention consists of individualised exercise training at home on
a treadmill, telemonitoring by a physiotherapist via videoconferencing using a tablet computer, and self-management
via a customised website. Patients in the treadmill arm are provided with a treadmill only to perform unsupervised
exercise training at home. Patients in the control arm are offered standard care. The primary outcome is the combined
number of hospitalisations and emergency department presentations. Secondary outcomes include changes in health
status, quality of life, anxiety and depression, self-efficacy, subjective impression of change, physical performance, level
of physical activity, and personal experiences in telerehabilitation.
Discussion: This trial will provide evidence on whether long-term telerehabilitation represents a cost-effective strategy
for the follow-up of patients with COPD. The delivery of telerehabilitation services will also broaden the availability
of PR and maintenance strategies, especially to those living in remote areas and with no access to centre-based
exercise programmes.
Trial registration: ClinicalTrials.gov: NCT02258646.
Keywords: COPD, Pulmonary rehabilitation, Telemedicine, Exercise, Home monitoring, Telerehabilitation
Abbreviations: 6MWD, 6-minute walking distance; AES, Advanced encryption standard; BCSS, Breathlessness, cough,
and sputum scale; CAT, COPD Assessment test; COPD, Chronic obstructive pulmonary disease; ED, Emergency
department; GSES, Generalised self-efficacy scale; HAD, Hospital anxiety and depression scale; PGIC, Patient global
impression of change scale; PR, Pulmonary rehabilitation; RCT, Randomised controlled trial; SIP, Session initiation protocol
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Background
Chronic obstructive pulmonary disease (COPD) is char-
acterised by a persistent airflow limitation that is usually
progressive [1]. Patients experience frequent acute exacer-
bations, characterised by worsening of respiratory symp-
toms [2] which may lead, in the worst cases, to a hospital
admission [3]. COPD poses a substantial burden on
healthcare budgets. The largest part of the health ser-
vice expenditure is for hospitalisations and emergency
department (ED) presentations, which commonly occur
in the latter stages of the disease [4]. Moreover, prior
hospitalisations represent a risk factor for rehospitalisa-
tion in patients discharged after a severe exacerbation
[5]. Hospital admissions for exacerbations do not only
represent a burden for the healthcare system, but have
also a negative impact on patients, who experience re-
duced physical activity, decreased exercise performance
[6], and impaired quality of life, even in mild stages of
the disease [7]. Dyspnoea, the most commonly reported
symptom during acute events, is associated with anxiety
and depression [8]. Importantly, reduced physical activity
is the strongest predictor of mortality in patients with
COPD [9].
Pulmonary rehabilitation (PR) is an evidence-based,
multidisciplinary, and comprehensive intervention for
the management of COPD [10–12]. The main goal is to
improve the physical and psychological condition and to
promote long-term adherence of health-enhancing be-
haviours [13]. Exercise training is the cornerstone of PR,
aiming to improve physical capacity and ability to per-
form activities of daily living. Other components include
patient assessment, behavioural change, education on self-
management, and psychosocial support [13]. PR improves
dyspnoea, physical performance, quality of life [10], and is
effective in reducing use of healthcare resources [14].
However, the short-term benefits diminish over the
succeeding 12 months without an effective maintenance
strategy [15]. Sustaining long-term adherence to exer-
cise training is difficult due to variation in day to-day
condition, exacerbations, hospital admissions, and trans-
portation problems [16]. Key factors which promote exer-
cise maintenance include professional support, review of
exercise intensity, goal setting, social support, positive
personal attributes, and the availability of exercise pro-
grammes with regular supervision [16]. Only a few in-
vestigators have explored maintenance strategies to sustain
the benefits of PR over the long term, with inconsistent
results [17–20].
Telemedicine has the potential to improve access to
PR and support long-term exercise maintenance strategies.
Telerehabilitation is the use of information and communi-
cation technologies to provide rehabilitation services re-
motely to people in their homes or other environments
[21]. In contrast to traditional centre-based programmes,
undertaking PR within the home environment may pro-
mote more effective integration of exercise routines
into daily life over the longer term [22]. Evidence of the
use of telemedicine in PR is still limited [13]. A recent
review showed that telemedicine was effective in in-
creasing physical activity levels in patients with COPD
[23]. A few studies, most of which uncontrolled, showed
promising results for short-term telerehabilitation inter-
ventions in regards to feasibility, safety, exercise capacity,
and health-related quality of life [24–29]. However, only
one uncontrolled pilot study trialled a long-term telereha-
bilitation intervention for patients with COPD [30]. This
study demonstrated positive outcomes in terms of exercise
maintenance, physical performance, health status and
quality of life [31]. Importantly, long-term adherence was
supported by experienced health benefits, self-efficacy,
emotional safety, and maintenance of motivation [32].
Larger controlled trials are needed to explore the long-
term effects of telerehabilitation in COPD.
Developing new cost-effective ways to sustain regular ex-
ercise over the long term and broaden the applicability and
availability of PR is an important goal in the COPD man-
agement. The aim of this study is to compare long-term
telerehabilitation of COPD patients consisting of exercise
training at home, telemonitoring, and self-management,
with unsupervised exercise training at home and with
standard care. We hypothesised that long-term telereh-
abilitation will reduce the number of hospital readmis-
sions and improve patient’s level of physical activity,
health status and quality of life. The results from this
study will provide decision makers, as well as practi-
tioners, evidence on whether telerehabilitation interven-
tions might be added to the current offer of traditional PR
programmes and maintenance strategies.
Methods/Design
Design
An international multicentre randomised controlled
trial (RCT) conducted across sites in three countries
(Norway, Australia, and Denmark), where 120 patients
with COPD are randomly assigned to three arms (tele-
rehabilitation, treadmill, control) in a 1:1:1 ratio and
followed up for 2 years. The trial is restricted to pa-
tients who have volunteered and provided written
informed consent in accordance with the Declaration
of Helsinki. The trial received approval from the
Regional Committee for Medical and Health Research
Ethics in Norway (2014/676/REK nord), the Alfred
Hospital Human Research Ethics Committee (289/14),
and the North Denmark Region Committee on Health
Research Ethics (N-20140038). The protocol of this
RCT fulfils the Standard Protocol Items: Recommenda-
tions for Interventional Trials (SPIRIT) guidelines
(Additional file 1).
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Eligibility criteria
To be eligible for enrolment, participants must have the
following inclusion criteria: 1) a diagnosis of COPD, based
on an FEV1/FVC ratio < 70 % [33], 2) moderate, severe or
very severe airflow limitation, with forced expiratory
volume in 1 s percentage (FEV1 % of predicted) < 80 %, 3)
at least one COPD-related hospitalisation or COPD-
related ED presentation in the 12 months prior to en-
rolment, 4) aged between 40 and 80 years, and 5)
capable of providing signed written informed consent.
Participants are excluded if they have at least one of
the following criteria: 1) attendance at a rehabilitation
programme in the 6 months prior to enrolment; 2) par-
ticipation in another clinical study that may have an
impact on the primary outcome, 3) deemed by the
healthcare team to be physically incapable of perform-
ing the study procedures, 4) presence of comorbidities
which, in the opinion of the healthcare team, might
prevent patients from safely undertaking an exercise
programme at home (for example severe orthopaedic or
neurological impairments, severe cognitive impairment),
and 5) home environment not suitable for installation and
use of rehabilitation and monitoring equipment. Potential
participants are not excluded on the basis of their
existing home Internet access, as this can be provided
by the study.
Randomisation
Randomisation is stratified by centre and disease
severity (FEV1 < 50 % vs. FEV1 ≥ 50 %) to preserve
homogeneity between arms with regard to severity of
clinical status. Randomisation is web-based and per-
formed via the WebCRF program developed by the
Unit for Applied Clinical Research at the Norwegian
University of Science and Technology in Trondheim.
The tool uses a computerised block randomisation,
and the size of the first, smallest and largest blocks is
established based on the total number of patients ex-
pected to be included in the study. The randomisation
sequence generated is concealed from the study team
by the program. The same WebCRF program is used
to fill out electronic case report forms (CRFs). This
allows patient data from several centres to be entered
into the same database.
Interventions
Telerehabilitation arm
Patients in the telerehabilitation arm are offered an
integrated intervention consisting of exercise training
at home, telemonitoring, and self-management. The equip-
ment includes: a) a treadmill (Sportsmaster T2 in Norway,
Sportsmaster T3i in Denmark, Reebok ZRK1 in Australia),
b) a pulse oximeter (Nonin 9570/9571), c) a tablet
computer (Apple iPad Air), and d) a holder for the
tablet computer (RAM) (Fig. 1). The feasibility of
using such equipment was tested in a previous pilot study
[30]. Videoconferencing is performed through Acano™
due to its ability to connect the participant’s tablet to vid-
eoconferencing protocol H.323 and Session Initiation
Protocol (SIP) standards-based systems, desktop com-
puters or mobile clients. Communication is performed
with Advanced Encryption Standard (AES) encryption
and features multiconferencing.
The exercise intervention consists of an individualised
training programme of regular exercise of continuous or
interval training on the treadmill and strength training
exercises according to current guidelines [13]. The
treadmill exercise programme lasts for at least 30 min.
Depending on the patient’s condition, a programme of
continuous training (moderate intensity - Borg scale [34]
ratings up to 4) or interval training (high intensity - Borg
scale ratings up to 6) is conducted. The frequency pre-
scribed is 3–5 times/week for continuous training and 3
times/week for interval training. For interval training, up
to 4 interval bouts of high intensity lasting from 1 to
4 min could be prescribed. Progression is made by
increasing speed and incline first. Then the patient is
encouraged to increase duration. Patients are permitted
to take short rests if intolerable symptoms occur, but
rest time does not count towards training duration. The
exercise programme can be modified by the physio-
therapist or the patients themselves according to their
conditions. Strength training is prescribed for a frequency
of 2–3 sessions per week. Each session includes at least
two lower limb exercises (6–12 repetitions, 3 sets) and
two upper limb exercises (6–12 repetitions, 1–3 sets). The
patients can choose between sit-to-stand, squat, step-up,
lunge, calf raise, biceps curl, shoulder press, wall push up,
bench press, standing row, seated row, lateral pull down,
triceps press. Bottles filled with sand/water or elastic
bands/free weights can be used for upper limb exercises if
already available in the patient’s home.
A customised website is used to access the individual
training programme, fill in a daily diary and a training
diary, review historical data, exchange electronic mes-
sages, schedule videoconferencing sessions, and assess
individual goal settings and goal attainment. Patients are
asked, every evening, to use their pulse oximeter at rest
and to fill the daily electronic diary on the website
including: a) oxygen saturation, b) heart rate, c) Breath-
lessness, Cough, and Sputum Scale (BCSS) [35], d)
general wellbeing (qualitative self-score on a five-point
Likert scale), and e) additional comments. During an
exercise session on the treadmill, patients are required
to self-monitor their oxygen saturation and heart rate.
After each exercise session, patients are asked to fill in
the electronic training diary on the website including: a)
programme completion, b) Borg CR10 scale - Rating of
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Perceived Exertion for leg (highest value during exercise),
c) Borg CR10 scale - Rating of Perceived Dyspnoea (high-
est value during exercise), d) oxygen saturation (lowest
value during exercise), e) heart rate (highest value during
exercise), and f) additional comments. The information
sent through the electronic forms is monitored and inter-
preted weekly by a physiotherapist, who also checks for
any out-of-range value. The physiotherapist can provide
feedback to the patients via the website, or use this infor-
mation in the upcoming videoconference. Patients are also
informed on the presence of signs and symptoms to en-
sure that they do not exercise if not recommended.
Patients have scheduled videoconferencing sessions with
the physiotherapist. During videoconferencing, patients
are encouraged to set specific goals for their ongoing
programme and their daily life activities. Self-management
education and training are provided to promote adherence
to health-enhancing behaviours. During disease exacerba-
tions, strength training exercises might be encouraged
until the patient gets well enough to exercise on the tread-
mill. If the patient reports changes on sputum aspect,
guidance on airway clearance techniques is offered (e.g.
active cycle of breathing). The physiotherapist can take
electronic notes using the same website. The frequency of
contacts consists of at least 1 individual videoconferencing
session/week in the first 8 weeks after enrolment, and at
least 1 individual videoconferencing session/month in the
following period. Participants who experience a hospital
admission during the study period are invited to continue
their participation after discharge. In these cases, at least 1
individual videoconferencing session/week will be applied
in the month after discharge as a reinforcement strategy.
Additional peer-group exercise sessions supervised by the
physiotherapist can be organised.
Treadmill arm
Patients in the treadmill arm are provided with a tread-
mill only to perform unsupervised exercise training at
home. The exercise intervention consists of an indivi-
dualised unsupervised training programme performed as
prescribed to the participants in the telerehabilitation
arm, without regular review or progression of the program.
Participants are asked to record each training session on a
paper-based diary. This intervention arm allows comparing
the effects of providing training equipment only to those
using telerehabilitation.
Control arm
Patients in the control arm are offered standard care. To
ensure that no participants are denied access to the best
health care practice, any participant in the trial can
undertake a traditional PR programme at any time
Fig. 1 Telerehabilitation in a participant’s home
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during the 2-year study period if it is considered clinic-
ally indicated by their usual treating team.
Recruitment and study procedures
At enrolment, a clinical assessment is performed for all
the patients by appropriately trained study personnel
blinded to group allocation. Participants are asked to
perform spirometry, the 6-min walking test [36] and
complete the study questionnaires (Table 1). Participants
are also provided brochures containing information about
PR, physical activity and training, diet, self-management,
motivation and lifestyle changes, smoking cessation and
oxygen therapy.
After enrolment, patients in the telerehabilitation and
the treadmill arms undergo a supervised session on the
treadmill with an experienced research physiotherapist
to learn how to safely exercise at home, receive informa-
tion on how to make progress in the programme and
are given the opportunity to clarify any questions related
to equipment management. Patients in the telerehabilita-
tion arm also receive training on the use of the study
website. A test videoconferencing session is also per-
formed by the local research team to guarantee proper
equipment functioning. Patients can always contact the
research team in case of technical issues.
At 6-month, 1-year and 2-year, patients undergo a
clinical reassessment and are asked to complete the
study questionnaires (Table 1). During data collection
patients are encouraged to continue participating in
the study. Patients are discharged from the trial after
2 years, those in the telerehabilitation and the tread-
mill arms can keep the equipment at the end of the
study.
Outcome measures
The primary outcome is the combined number of hos-
pitalisations and ED presentations. Differences in the
rate of events between the study arms will be measured
at all assessment time points (Table 2). Data on hospi-
talisations and ED presentations, together with out-
patient visits, will be collected from hospitals records
(in Australia), regional systems (in Denmark) and national
registries (in Norway). Details will include institution, date
of admission, date of discharge, diagnosis-related group
(DRG), diagnoses, procedures and associated cost. In
addition, use of hospital resources will be recorded
during the follow-up visits. Hospitalisations and ED
presentations will be also analysed separately as secondary
outcomes. Mortality will be monitored along the study
together with dropouts.
Health status will be measured with the COPD Assess-
ment Test (CAT) [37]. Health-related quality of life will be
measured with the EQ-5D questionnaire [38]. Levels of
anxiety and depression will be measured with the Hospital
Anxiety and Depression Scale (HAD) [39]. Self-efficacy
will be measured with the Generalised Self-Efficacy Scale
(GSES) [40]. Subjective impression of overall change will
be measured with the Patient global impression of change
scale (PGIC) [41]. The study questionnaires, available in
English, Norwegian and Danish with validated versions,
will be collected along the study at different time points
(Table 1).
Functional exercise capacity will be measured with the
6-min walking distance (6MWD). The 6-min walking
Table 1 Data collected at baseline and follow-up visits
Data collected Baseline 6-month 1-year 2-year
Clinical history and patient’s
characteristics
X
Pharmacological treatment X
Spirometry X X X X
6-min walking test X X X X
MMRC Dyspnoea Scale X X X X
COPD Assessment Test X X X X
EQ-5D Health Questionnaire X X X X
Generalised Self-Efficacy Scale X X X X
Hospital Anxiety and
Depression Scale
X X X X
Level of physical activity X X X X
Healthcare utilisation X X X
Patient Global Impression of Change X
Table 2 Primary and secondary outcomes and related measures
Outcome Measure
Primary outcome
• Combined number of
hospitalisations and
ED presentations
• Incidence Density
Secondary outcomes
• Hospitalisations
• ED presentations
• Mortality
• Time free from first event
• Health status
• Quality of life
• Anxiety and depression
• Self-efficacy
• Subjective impression of
overall change
• Physical performance
• Level of physical activity
• Incidence Density
• Incidence Density
• Mortality rate
• Days to first hospitalisation
or ED presentation
• COPD Assessment Test
• EQ-5D
• Hospital Anxiety and Depression
Scale (HAD)
• Generalised Self-Efficacy Scale (GSES)
• Patient global impression of change
scale (PGIC)
• 6-min walking distance (6MWD)
• Daily number of steps, minutes of
moderate to vigorous physical activity
and sedentary time during 1-week
• Cost-effectiveness
• Experiences in
telerehabilitation
• Cost-utility analysis (cost-per-QALY)
• Qualitative interviews with
semi-structured questions
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test will be performed twice according to guidelines, and
the furthest distance recorded [36].
Objective physical activity assessment will be under-
taken using the SenseWear Armband (SWA; BodyMedia,
Pittsburgh, USA; professional software version 7.0). The
SWA will be positioned on the participant’s left upper arm
according to manufacturer instructions. Participants will
be instructed to wear the SWA for 1 week, only removing
it for bathing or water-based activities. The first and
last days of data will be excluded from analysis upon
data retrieval. A day of data (midnight to 23:59) will be
included for analysis if there is at least 10 h of data
within the 24-h period. A minimum of four valid days
of data will be required per participant at each assess-
ment time point [42], inclusive of at least 1 weekend
day. The proprietary algorithm provides a range of vari-
ables for each minute of wear time, including energy
expenditure and number of steps. The intensity of
physical activity is described according to metabolic
equivalents (1 MET = 1 kcal/kg/h). Each minute of wear
time will be allocated to a category of physical activity
on the basis of MET classification (sedentary ≤ 1.5
METs, moderate and vigorous ≥ 3 METs). The amount
of time spent in moderate to vigorous physical activity,
and time spent sedentary, will be calculated.
A cost-utility analysis will be performed to verify
whether the telerehabilitation and the treadmill interven-
tions are cost-effective. The perspective of the healthcare
authority will be adopted with respect to costs. The fol-
lowing cost components will be included in the analysis:
a) hospital resources, b) delivery of the telerehabilitation
intervention, and c) equipment. Hospital resources will in-
clude hospitalisations, ED presentations, outpatient visits,
and rehabilitation. Unit cost for each resource will be
based on the specific public tariffs from the national DRG
system. Delivery of the telerehabilitation intervention will
include the time used by the project team to install the
equipment in the patient’s home and provide training, and
the time used by the physiotherapist to supervise the pa-
tients. Equipment costs for the telerehabilitation arm and
the intervention arm will be calculated based on a 5-year
amortisation period. All costs will be expressed in Euros
(€). Utility will be measured in terms of quality adjusted
life years (QALYs), based on the answers of the EQ-5D
questionnaires at baseline, 6 month, 1–2 years. Utility
values will be calculated using the European EQ-net VAS
set, and only if all the five dimensions are answered. The
incremental cost-effectiveness ratio will be computed as
differential costs and differential QALYs.
Patients’ perspectives in participating in long-term
telerehabilitation will be explored through qualitative in-
terviews with semi-structured questions. Interviews will
be conducted before telerehabilitation, after 1 year and
after 2 years, with 5–8 patients in the telerehabilitation
arm at each site. Interviews will be recorded on audio
digital file, transcribed verbatim and analysed via
Nvivo 10.0 upon the theoretical frame of the learning
theory [43].
Adverse events and dropouts
Adverse events, including deaths, treadmill injuries and
other unspecified reasons, will be recorded in the
WebCRF program. Technical problems will be recorded
by each participating centre into a separate database.
Dropouts will occur if patients notify the research team
that they do not want to participate any longer to the
study and therefore withdraw their consent. In this
case the project team might collect the equipment
upon request. Patients who do not participate actively
in the intervention will still be included in the study,
and analysed according to the intention-to-treat ap-
proach. They will keep the project equipment as long
as they want.
Statistical analysis
Descriptive statistics at baseline will be reported as
means ± SD for normally distributed continuous variables,
or medians with 25–75th percentiles in the case of skewed
distribution. Normality of distribution will be tested by
means of the nonparametric Kolmogorov-Smirnov test.
An intention-to-treat analysis will be performed on all
randomised subjects to provide unbiased comparisons
among groups and avoid the effects of dropout. The pri-
mary outcome and related secondary outcomes will be
measured through the Incidence Density, defined as the
number of events in a group divided by the total person-
time accumulated during the study in that group [44].
Differences between study arms will be tested by the
Comparison of Incidence Rates. A two-sided test and a
significance level of α = 0.05 will be used. All events from
the day after randomisation to patient exit/death will be
included. Other secondary outcomes will be measured as
changes from baseline to all assessment time points.
Changes of the secondary outcomes will be tested by use
of linear mixed models, which allow accounting for re-
peated measures collected in a longitudinal design. More-
over, linear mixed models deal better with dropouts that
other methods used for repeated measures, and use of
imputation techniques for missing data is not necessary. A
p-value <0.05 will be considered significant for all tests.
All statistical analyses will be performed by using IBM
SPSS Statistics.
Sample size
The sample size requirements for this study were intended
to provide adequate power for the analysis of the primary
outcome. From studies with patients with similar charac-
teristics [45–48], we estimated an incidence density used
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as a null hypothesis of 2 events per person-year, and a
40 % relative reduction in the primary outcome. In a
major study of a management programme including home
exercises for COPD patients after acute exacerbations [46]
the mean number of hospital admissions per patient was
reduced from 1.6 to 0.9 in the year following a hospital
admission. We calculated that a sample size of 65 person-
years per group would allow a power of 95 % to detect an
incidence rate ratio of 0.60, with a type-I error (α) of 0.05.
Assuming that up to 20 % of patients may drop out
uniformly over the intervention period, 40 patients
(corresponding to 80 person-years) will be enrolled per
each of the three arms for the 2-year study duration. In
total, 120 patients (corresponding to 240 person-years)
will therefore be enrolled in the study. Recruitment is
expected to be concluded by the end of 2016.
Discussion
This study protocol described the methods used in this first
RCT investigating the effects of long-term telerehabilitation
in COPD. Patients with COPD often experience repeated
exacerbations which lead to a worsening of their health
condition and to hospital admissions [3]. Moreover, hos-
pital readmissions are more likely to occur in patients with
prior history of hospitalisations [5]. There is an increasing
need for cost-effective treatment strategies for patients
with COPD [22]. PR is a low-cost, integral component of
COPD management [12]. PR is traditionally centre-based
and offered either as a 6–12-week outpatient programme
or as a 4-week inpatient programme. Available resources
for PR are often limited, and patients living in rural areas
especially suffer from poor availability of PR programmes
[49]. Maintenance strategies are needed to sustain the
benefits of PR over the long term [15]. However, these
are scarcely documented, and the optimal combination
of maintenance interventions after completion of a PR
programme remains unknown [12]. Long-term telereh-
abilitation is an innovative intervention which might
reduce hospital readmissions in COPD and thus limit
healthcare utilisation. The results of this study will pro-
vide evidence on whether long-term telerehabilitation
represents a cost-effective strategy for the follow-up of
patients with COPD. The delivery of telerehabilitation
services will also broaden the availability of PR and
maintenance strategies, especially to those living in re-
mote areas and with no access to centre-based exercise
programmes.
Significant improvements in outcomes can be ob-
tained with both supervised and unsupervised home
exercise [50]. However, sustaining long-term exercise
is generally difficult [17] for many reasons, including
professional support, regular supervision [16], emo-
tional safety, and maintenance of motivation [32]. We
expect that standard care and unsupervised home
exercise will be less beneficial than a telerehabilitation
intervention where patients are supervised regularly by
a physiotherapist via videoconferencing. The study was
designed as a three-armed RCT to isolate the effects of
placing training equipment in the patient’s home from
those of telemonitoring.
Trial status
Patient recruitment commenced in October 2014 and is
continuing.
Additional file
Additional file 1: SPIRIT checklist. (DOC 121 kb)
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